To amend the Federal Food, Drug, and Cosmetic Act to modernize the methods of authenticating controlled substances in the pharmaceutical distribution supply chain, and for other purposes.
About This Bill
Committee
Latest Action · May 3, 2022
Referred to the House Committee on Energy and Commerce.